Identification of potential therapeutic targets for idiopathic pulmonary fibrosis: an integrated multiomics analysis - Top-Institutions - MDSpire

Identification of potential therapeutic targets for idiopathic pulmonary fibrosis: an integrated multiomics analysis

  • By

  • Xingxuan Chen

  • Shibin Chen

  • Shuai Zhao

  • Yupeng Li

  • Jingkun Chang

  • Si Shi

  • Dandan Xu

  • Lijuan Li

  • Hong Chen

  • June 5, 2026

  • 0 min

Share

Top Institutions in Pulmonary

Brief introduction explaining scope and methodology.

  • #1

    UK Biobank
    UK Biobank

    London, England

    Key Differentiators

    • Genomics
    • Biobanking

  • #2

    National Center for Biotechnology Information (NCBI) Gene Expression Omnibus
    National Center for Biotechnology Information (NCBI) Gene Expression Omnibus

    Bethesda, Maryland

    Key Differentiators

    • Bioinformatics
    • Genomics

  • #3

    Lung Cancer Mutation Consortium
    Lung Cancer Mutation Consortium

    Various, Various

    Key Differentiators

    • Oncology
    • Genetics

Original Source(s)

Identification of potential therapeutic targets for idiopathic pulmonary fibrosis: an integrated multiomics analysis

  • by Xingxuan Chen, Shibin Chen, Shuai Zhao, Yupeng Li, Jingkun Chang, Si Shi, Dandan Xu, Lijuan Li, Hong Chen

  • June 5, 2026

Related Content

Case Report: Torque teno virus identified in pleural effusion of pediatric severe Mycoplasma pneumoniae pneumonia: diagnostic and therapeutic implications

Restoring balance in atopic disorders: insights into type 2 immunity and chronic inflammation

Construction and validation of a machine learning-based prediction model for venous thromboembolism in lung transplant recipients supported by ECMO